Nigeria Pharmaceuticals & Healthcare Report Q3 2014
The Nigerian pharmaceutical industry continues to show strong growth reaffirming our positive outlook for this quarter. An increase in urbanisation, per capita incomes and non-communicable diseases will drive the demand of medicines along with the government's goals to make healthcare more accessible and widespread throughout the country. However, the likelihood of further divestment in the oil and gas sector alongside political tensions within the ruling party in the lead-up to the 2015 election could have implications for future healthcare investments.
This report does not have a Table of Contents available
This report does not have a list of Companies Mentioned available
This report does not have a press release associated with it